This book progressively shifts and guides the readers from basic underlying mechanisms to translational approaches to treat cancer.
This book will present molecular basis of cancer development, progression and development of resistance against wide ranging therapeutics information
Book is appropriately designed for established oncologists, basic and medical students and pharmaceutical industry associated R&D departments
Useful for training graduate medical students
Includes supplementary material: sn.pub/extras
This is a preview of subscription content, access via your institution.
Table of contents (14 chapters)
About this book
- Adenosine signaling pathways
- Blood-based cancer detection
- Cancer therapy
- Microtubule targeting agents
- Non-coding RNA
- Virus caused cancer
Editors and Affiliations
Institute of Biomedical and Genetic Engineering (IBGE), Islamabad, Pakistan
Ammad Ahmad Farooqi, Muhammad Ismail
About the editors
Ammad Ahmad Farooqi is currently a Senior Scientist at the Institute of Biomedical and Genetic Engineering (IBGE), in Islamabad, Pakistan. His area of research is tightly focused on cancer genetics and therapeutics.
Professor Muhammad Ismail has a Ph.D. in Biotechnology and is currently the Director of the Institute of Biomedical and Genetic Engineering (IBGE), in Islamabad. His main focus of research is Cancer Genetics and Therapeutics, Nanomedicine and Pharmacogenomics.
Book Title: Molecular Oncology: Underlying Mechanisms and Translational Advancements
Editors: Ammad Ahmad Farooqi, Muhammad Ismail
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing AG 2017
Hardcover ISBN: 978-3-319-53081-9Published: 05 April 2017
Softcover ISBN: 978-3-319-85057-3Published: 21 July 2018
eBook ISBN: 978-3-319-53082-6Published: 29 March 2017
Edition Number: 1
Number of Pages: X, 302
Number of Illustrations: 3 b/w illustrations, 24 illustrations in colour
Topics: Cancer Biology, Oncology